Ascension Providence is a 349-bed high-rise hospital in the U.S. city of Mobile, Alabama. The hospital tower was completed in 1987. The building sits at the center of a 277-acre campus, it rises approximately 170 feet and 11 stories.

During the past decade, Providence Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 36 clinical trials were completed, i.e. on average, 3600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored and "Agennix" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Providence Hospital" are "Recurrent Breast Carcinoma" (3 trials), "Recurrent Melanoma" (3 trials), "Acute Myocardial Infarction" (2 trials), "Breast Adenocarcinoma" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Providence Hospital" in a lesser frequency.

Most popular intervention types in "Providence Hospital" are "Drug" (44 trials), "Other" (32 trials), "Biological" (22 trials), "Radiation" (9 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Quality-of-Life Assessment" (14 trials), "Bevacizumab" (12 trials), "Placebo" (8 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Providence Hospital" are 40 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Hospital". undefined are not yet recruiting, 1 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Providence Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Hospital, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".